An analysis of appropriate delivery of postoperative radiation therapy for endometrial cancer using the RAND/UCLA Appropriateness Method: Executive summary

Ellen Jones, Sushil Beriwal, David Beyer, Junzo Chino, Anuja Jhingran, Larissa Lee, Jeff Michalski, Arno J. Mundt, Caroline Patton, Ivy Petersen, Lorraine Portelance, Julie K. Schwarz, Susan McCloskey

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose To summarize the results of American Society for Radiation Oncology (ASTRO)’s analysis of appropriate delivery of postoperative radiation therapy (RT) for endometrial cancer using the RAND/University of California, Los Angeles (UCLA) Appropriateness Method, outline areas of convergence and divergence with the 2014 ASTRO endometrial Guideline, and highlight where this analysis provides new information or perspective. Methods and materials The RAND/UCLA Appropriateness Method was used to combine available evidence with expert opinion. A comprehensive literature review was conducted and a multidisciplinary panel rated the appropriateness of RT options for different clinical scenarios. Treatments were categorized by the median rating as Appropriate, Uncertain, or Inappropriate. Results The ASTRO endometrial Guideline and this analysis using the RAND/UCLA Appropriateness Method did not recommend adjuvant RT for early-stage, low-risk endometrioid cancers and largely agree regarding use of vaginal brachytherapy for low-intermediate and high-intermediate risk patients. For more advanced endometrioid cancer, chemotherapy with RT is supported by both documents. The Guideline and the RAND/UCLA analysis diverged regarding use of pelvic radiation. For stages II and III, this analysis rated external beam RT plus vaginal brachytherapy Appropriate, whereas the Guideline preferred external beam alone. In addition, this analysis offers insight on the role of histology, extent of nodal dissection, and para-aortic nodal irradiation; the use of intensity modulated RT; and management of stage IVA. Conclusions This analysis based on the RAND/UCLA Method shows significant agreement with the 2014 endometrial Guideline. Areas of divergence, often in scenarios with low-level evidence, included use of external beam RT plus vaginal brachytherapy in stages II and III and external beam RT alone in early-stage patients. Furthermore, the analysis explores other important questions regarding management of this disease site.

Original languageEnglish (US)
Pages (from-to)26-34
Number of pages9
JournalAdvances in Radiation Oncology
Volume1
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Los Angeles
Endometrial Neoplasms
Radiotherapy
Radiation Oncology
Guidelines
Brachytherapy
Expert Testimony
Disease Management
Dissection
Neoplasms
Histology
Radiation
Drug Therapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

An analysis of appropriate delivery of postoperative radiation therapy for endometrial cancer using the RAND/UCLA Appropriateness Method : Executive summary. / Jones, Ellen; Beriwal, Sushil; Beyer, David; Chino, Junzo; Jhingran, Anuja; Lee, Larissa; Michalski, Jeff; Mundt, Arno J.; Patton, Caroline; Petersen, Ivy; Portelance, Lorraine; Schwarz, Julie K.; McCloskey, Susan.

In: Advances in Radiation Oncology, Vol. 1, No. 1, 01.01.2016, p. 26-34.

Research output: Contribution to journalArticle

Jones, E, Beriwal, S, Beyer, D, Chino, J, Jhingran, A, Lee, L, Michalski, J, Mundt, AJ, Patton, C, Petersen, I, Portelance, L, Schwarz, JK & McCloskey, S 2016, 'An analysis of appropriate delivery of postoperative radiation therapy for endometrial cancer using the RAND/UCLA Appropriateness Method: Executive summary', Advances in Radiation Oncology, vol. 1, no. 1, pp. 26-34. https://doi.org/10.1016/j.adro.2015.10.001
Jones, Ellen ; Beriwal, Sushil ; Beyer, David ; Chino, Junzo ; Jhingran, Anuja ; Lee, Larissa ; Michalski, Jeff ; Mundt, Arno J. ; Patton, Caroline ; Petersen, Ivy ; Portelance, Lorraine ; Schwarz, Julie K. ; McCloskey, Susan. / An analysis of appropriate delivery of postoperative radiation therapy for endometrial cancer using the RAND/UCLA Appropriateness Method : Executive summary. In: Advances in Radiation Oncology. 2016 ; Vol. 1, No. 1. pp. 26-34.
@article{402dcdcaddfe47abb89050905066f27a,
title = "An analysis of appropriate delivery of postoperative radiation therapy for endometrial cancer using the RAND/UCLA Appropriateness Method: Executive summary",
abstract = "Purpose To summarize the results of American Society for Radiation Oncology (ASTRO)’s analysis of appropriate delivery of postoperative radiation therapy (RT) for endometrial cancer using the RAND/University of California, Los Angeles (UCLA) Appropriateness Method, outline areas of convergence and divergence with the 2014 ASTRO endometrial Guideline, and highlight where this analysis provides new information or perspective. Methods and materials The RAND/UCLA Appropriateness Method was used to combine available evidence with expert opinion. A comprehensive literature review was conducted and a multidisciplinary panel rated the appropriateness of RT options for different clinical scenarios. Treatments were categorized by the median rating as Appropriate, Uncertain, or Inappropriate. Results The ASTRO endometrial Guideline and this analysis using the RAND/UCLA Appropriateness Method did not recommend adjuvant RT for early-stage, low-risk endometrioid cancers and largely agree regarding use of vaginal brachytherapy for low-intermediate and high-intermediate risk patients. For more advanced endometrioid cancer, chemotherapy with RT is supported by both documents. The Guideline and the RAND/UCLA analysis diverged regarding use of pelvic radiation. For stages II and III, this analysis rated external beam RT plus vaginal brachytherapy Appropriate, whereas the Guideline preferred external beam alone. In addition, this analysis offers insight on the role of histology, extent of nodal dissection, and para-aortic nodal irradiation; the use of intensity modulated RT; and management of stage IVA. Conclusions This analysis based on the RAND/UCLA Method shows significant agreement with the 2014 endometrial Guideline. Areas of divergence, often in scenarios with low-level evidence, included use of external beam RT plus vaginal brachytherapy in stages II and III and external beam RT alone in early-stage patients. Furthermore, the analysis explores other important questions regarding management of this disease site.",
author = "Ellen Jones and Sushil Beriwal and David Beyer and Junzo Chino and Anuja Jhingran and Larissa Lee and Jeff Michalski and Mundt, {Arno J.} and Caroline Patton and Ivy Petersen and Lorraine Portelance and Schwarz, {Julie K.} and Susan McCloskey",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.adro.2015.10.001",
language = "English (US)",
volume = "1",
pages = "26--34",
journal = "Advances in Radiation Oncology",
issn = "2452-1094",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - An analysis of appropriate delivery of postoperative radiation therapy for endometrial cancer using the RAND/UCLA Appropriateness Method

T2 - Executive summary

AU - Jones, Ellen

AU - Beriwal, Sushil

AU - Beyer, David

AU - Chino, Junzo

AU - Jhingran, Anuja

AU - Lee, Larissa

AU - Michalski, Jeff

AU - Mundt, Arno J.

AU - Patton, Caroline

AU - Petersen, Ivy

AU - Portelance, Lorraine

AU - Schwarz, Julie K.

AU - McCloskey, Susan

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Purpose To summarize the results of American Society for Radiation Oncology (ASTRO)’s analysis of appropriate delivery of postoperative radiation therapy (RT) for endometrial cancer using the RAND/University of California, Los Angeles (UCLA) Appropriateness Method, outline areas of convergence and divergence with the 2014 ASTRO endometrial Guideline, and highlight where this analysis provides new information or perspective. Methods and materials The RAND/UCLA Appropriateness Method was used to combine available evidence with expert opinion. A comprehensive literature review was conducted and a multidisciplinary panel rated the appropriateness of RT options for different clinical scenarios. Treatments were categorized by the median rating as Appropriate, Uncertain, or Inappropriate. Results The ASTRO endometrial Guideline and this analysis using the RAND/UCLA Appropriateness Method did not recommend adjuvant RT for early-stage, low-risk endometrioid cancers and largely agree regarding use of vaginal brachytherapy for low-intermediate and high-intermediate risk patients. For more advanced endometrioid cancer, chemotherapy with RT is supported by both documents. The Guideline and the RAND/UCLA analysis diverged regarding use of pelvic radiation. For stages II and III, this analysis rated external beam RT plus vaginal brachytherapy Appropriate, whereas the Guideline preferred external beam alone. In addition, this analysis offers insight on the role of histology, extent of nodal dissection, and para-aortic nodal irradiation; the use of intensity modulated RT; and management of stage IVA. Conclusions This analysis based on the RAND/UCLA Method shows significant agreement with the 2014 endometrial Guideline. Areas of divergence, often in scenarios with low-level evidence, included use of external beam RT plus vaginal brachytherapy in stages II and III and external beam RT alone in early-stage patients. Furthermore, the analysis explores other important questions regarding management of this disease site.

AB - Purpose To summarize the results of American Society for Radiation Oncology (ASTRO)’s analysis of appropriate delivery of postoperative radiation therapy (RT) for endometrial cancer using the RAND/University of California, Los Angeles (UCLA) Appropriateness Method, outline areas of convergence and divergence with the 2014 ASTRO endometrial Guideline, and highlight where this analysis provides new information or perspective. Methods and materials The RAND/UCLA Appropriateness Method was used to combine available evidence with expert opinion. A comprehensive literature review was conducted and a multidisciplinary panel rated the appropriateness of RT options for different clinical scenarios. Treatments were categorized by the median rating as Appropriate, Uncertain, or Inappropriate. Results The ASTRO endometrial Guideline and this analysis using the RAND/UCLA Appropriateness Method did not recommend adjuvant RT for early-stage, low-risk endometrioid cancers and largely agree regarding use of vaginal brachytherapy for low-intermediate and high-intermediate risk patients. For more advanced endometrioid cancer, chemotherapy with RT is supported by both documents. The Guideline and the RAND/UCLA analysis diverged regarding use of pelvic radiation. For stages II and III, this analysis rated external beam RT plus vaginal brachytherapy Appropriate, whereas the Guideline preferred external beam alone. In addition, this analysis offers insight on the role of histology, extent of nodal dissection, and para-aortic nodal irradiation; the use of intensity modulated RT; and management of stage IVA. Conclusions This analysis based on the RAND/UCLA Method shows significant agreement with the 2014 endometrial Guideline. Areas of divergence, often in scenarios with low-level evidence, included use of external beam RT plus vaginal brachytherapy in stages II and III and external beam RT alone in early-stage patients. Furthermore, the analysis explores other important questions regarding management of this disease site.

UR - http://www.scopus.com/inward/record.url?scp=84995468869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995468869&partnerID=8YFLogxK

U2 - 10.1016/j.adro.2015.10.001

DO - 10.1016/j.adro.2015.10.001

M3 - Article

AN - SCOPUS:84995468869

VL - 1

SP - 26

EP - 34

JO - Advances in Radiation Oncology

JF - Advances in Radiation Oncology

SN - 2452-1094

IS - 1

ER -